INTRANASALE VERABREICHUNG

Patent europeic · EP3220989 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3220989
Numer da la dumonda
EP15798061
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-11-2015
Publitgà
27-09-2017
Concedì
24-06-2020
La protecziun finescha il pli tard
18-11-2035
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61M 15/08 (2006.01)
A61M 15/00 (2006.01)
Prioritad
US 201462081742 P 19.11.2014
Dumonda PCT
PCT/EP2015/077166 19.11.2015
Publicaziun PCT
WO2016/079271 26.05.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 29-12-2025

    Midada

    Published in Swissreg on 29.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 18-10-2022

    Transferì

    Owner
    Optinose AS, Postboks 288 Roa, 0702 Oslo, Norway → OPTINOSE, INC., 1020 Stony Hill Road, Ste 300, Yardley, PA 19067, USA

    Published in Swissreg on 18.10.2022

  6. 05-08-2020

    Represchentant inscrit

    Representative
    Hepp Wenger Ryffel AG, Friedtalweg 5, 9500 Wil / SG

    Published in Swissreg on 05.08.2020

  7. 24-06-2020

    Concedì

    Published in Swissreg on 24.06.2020

Partidas

Inventur

DJUPESLAND, Per Gisle

N-0702 Oslo, NO

SHELDRAKE, Colin David

South Marston Park Wiltshire SN3 4TG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.